MyEnterix has pioneered a patch clamp recording technique of in situ human intestinal neurons (EnteroPatch®) EnteroPatch is the first routine technique available at investigating the human nervous system. MyEnterix is a Biotech company created in 2012 which offers: - a unique model of living human neuron to his customers drug and target validation on human neurons as early as preclinical phase - enteric neuronal assays to probe “medical food” and probiotic efficiencies Thanks to its leading team of scientists with an outstanding experience in electrophysiology, pharmacology and cell biology, MyEnterix offers comprehensive integrated services on gastro-intestinal discovery.
| Website | http://www.myenterix.com |
| Revenue | $200000 |
| Employees | 1 (1 on RocketReach) |
| Founded | 2012 |
| Address | Faculté de Médecine - Secteur Nord, Marseille, Provence-Alpes-Cote d'Azur 13344, FR |
| Industry | Biotechnology, Drug Discovery, Pharmaceuticals, Other Healthcare Technology Systems, Healthcare |
| Keywords | Biotech, Electrophysiology, Biotechnology, Drug Discovery, Gastrointestinal, Neuroscience, Cell Biology, Innovative Techniques, Human Physiology, Biological Research, Research Tools, Pharmaceutical, Medical Technology, Scientific Research |
| Competitors | Medtronic, Boston Scientific, Olympus Corporation, FUJIFILM Business Innovation Asia Pacific, Abbott, Stryker, Smith+Nephew, Hologic, Inc., Cook Medical, CR Bard - Europe, Middle East and Africa (EMEA) +39 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular MyEnterix employee's phone or email?
The MyEnterix annual revenue was $200000 in 2026.
Eric di Pasquale is the Founder, Director R and D of MyEnterix.
1 people are employed at MyEnterix.
MyEnterix is based in Marseille, Provence-Alpes-Cote d'Azur.
The NAICS codes for MyEnterix are [325, 3254, 32].
The SIC codes for MyEnterix are [283, 28].